Value of Soluble CD14 (Presepsin) in Diagnosis of Bacterial Sepsis in Patients with Chronic Liver Disease
Ghoneim, E., Abd ElAziz, A., AbuAmer, A., Ghonaim, A., Awad, S. (2024). Value of Soluble CD14 (Presepsin) in Diagnosis of Bacterial Sepsis in Patients with Chronic Liver Disease. EKB Journal Management System, 33(1), 1-10. doi: 10.21608/ejmm.2024.325648
Enas M. Ghoneim; Azza M. Abd ElAziz; Ahmed M. AbuAmer; Alaa M. Ghonaim; Samah M. Awad. "Value of Soluble CD14 (Presepsin) in Diagnosis of Bacterial Sepsis in Patients with Chronic Liver Disease". EKB Journal Management System, 33, 1, 2024, 1-10. doi: 10.21608/ejmm.2024.325648
Ghoneim, E., Abd ElAziz, A., AbuAmer, A., Ghonaim, A., Awad, S. (2024). 'Value of Soluble CD14 (Presepsin) in Diagnosis of Bacterial Sepsis in Patients with Chronic Liver Disease', EKB Journal Management System, 33(1), pp. 1-10. doi: 10.21608/ejmm.2024.325648
Ghoneim, E., Abd ElAziz, A., AbuAmer, A., Ghonaim, A., Awad, S. Value of Soluble CD14 (Presepsin) in Diagnosis of Bacterial Sepsis in Patients with Chronic Liver Disease. EKB Journal Management System, 2024; 33(1): 1-10. doi: 10.21608/ejmm.2024.325648

Value of Soluble CD14 (Presepsin) in Diagnosis of Bacterial Sepsis in Patients with Chronic Liver Disease

Egyptian Journal of Medical Microbiology
Volume 33, Issue 1, January 2024, Page 1-10  XML PDF (343.47 K)
Document Type: New and original researches in the field of Microbiology.
DOI: 10.21608/ejmm.2024.325648
View on SCiNiTO View on SCiNiTO
Authors
Enas M. Ghoneim1; Azza M. Abd ElAziz1; Ahmed M. AbuAmer2; Alaa M. Ghonaim email orcid 1; Samah M. Awad1
1Clinical Microbiology & Immunology Department, National Liver Institute, Menoufia University-Shebin El-Kom-Egypt
2Hepatology Department, National Liver Institute, Menoufia University- Shebin El-Kom -Egypt
Abstract
Background: Sepsis in chronic liver disease (CLD) patients with high mortality and morbidity rates. Therefore, early detection in these patients may improve prognosis of the disease. CD14 may be a promising biomarker in the diagnosis of sepsis. Objectives:  Our study aimed to evaluate presepsin (sCD14) as an early diagnostic marker in septic patients with CLD. Its value was compared to that of CRP, and total leucocytic count (TLC) for diagnosis of bacterial infection. Methodology: The study included 60 patients with sepsis in addition to 30 healthy subjects as controls. Complete blood count, CRP, liver and renal function tests as well as blood culture were performed. Identification of the isolated organisms and antibiotic susceptibility testing were performed using VITEK2 compact system and sCD14 was measured by ELISA. Results: Levels of sCD14 were significantly higher (P<0.001) in septic patients compared with controls. ROC curve revealed that the sCD14 had a higher diagnostic performance than that of CRP and TLC (P<0.001).  The sCD14, at cutoff level greater than 0.89 mg/L, had 91.67% sensitivity and 63.33% specificity. Conclusion: sCD14 is more sensitive and specific for diagnosis of sepsis compared with CRP and TLC.
Keywords
Presepsin; soluble CD14; chronic liver disease; sepsis
Statistics
Article View: 197
PDF Download: 74